Article Details

EC approves Takeda's ADC for stage IIb Hodgkin lymphoma - Pharmaceutical Technology

Retrieved on: 2025-06-04 13:51:37

Tags for this article:

Click the tags to see associated articles and topics

EC approves Takeda's ADC for stage IIb Hodgkin lymphoma - Pharmaceutical Technology. View article details on hiswai:

Excerpt

EC approves Takeda ADC plus chemo for stage IIb Hodgkin's lymphoma · Intensified Biomanufacturing of monoclonal antibodies · Go deeper with GlobalData.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo